Latest Strategy Changes News

Canadian Phosphate Limited reported a steady rise in Q1 sales to $534,000, driven by US demand, with a significant capacity expansion at a key customer set to boost Q2 performance. The company also advances exploration and permitting efforts amid shifting North American phosphate dynamics.

White Cliff Minerals has initiated a significant drilling campaign at its Rae and Danvers copper projects, revealing extensive visible sulphide mineralisation, while also advancing its balance sheet through the sale of the Reedy South Gold Project for A$1.2 million.

Andromeda Metals has entered exclusive negotiations for a $75 million debt facility to fund the Stage 1A+ development of its Great White Project, alongside operational progress and exploration drilling.

American Rare Earths has expanded its Halleck Creek rare earth resource by 12.2% and achieved a metallurgical breakthrough that slashes processing volumes by over 90%, underpinning a robust updated scoping study with strong financial metrics.

My Rewards International has completed its acquisition of Fly Wallet and strengthened its financial position with a $15 million put option facility, while working to lift its ASX trading suspension.

Careteq Limited reports strong Q3 FY25 progress with near completion of its 1-System platform integration, revenue growth exceeding forecasts, and new strategic partnerships broadening its healthcare footprint.

Avira Resources has significantly expanded its Tangadee Project in Western Australia and is preparing to drill three high-potential EM targets, while advancing its capital raising efforts to fund exploration.

BOA Resources Ltd reported a steady cash position of AUD 1.067 million at the end of Q1 2025, underpinning an estimated four quarters of operational funding. The quarterly cash flow report highlights disciplined spending amid ongoing exploration activities.

BOA Resources is progressing its 2025 drilling plans across key lithium and nickel tenements in Western Australia, while managing delays in heritage surveys and optimizing its tenement portfolio to focus on high-potential assets.

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.

Aeris Environmental Ltd posted solid March quarter results, driven by its AerisTech joint venture’s initial hardware and software sales and expanding consumables segment. The company is leveraging new sustainability regulations to position its smart building ecosystem for growth.

Holista Colltech has closed its ASIC penalty chapter with a $900K final payment, raised $1.53 million through convertible notes, and reported a 10.9% year-on-year sales increase driven by its Dietary Supplements division.